A124869-100MG
A124869-10MG
A124869-25MG
A124869-500MG
A124869-50MG
A124869-5MG
ALA124869100MGEA
131.01
USD
InStock
ALA124869100MG
ALA124869-10MG
ALA124869-25MG
ALA124869500MG
ALA124869-50MG
ALA124869-5MG
ABT-199 ≥99%, Moligand™
ABT-199
ABT-199 (GDC-0199) is a BH3 mimetic that Bcl-2-selective inhibitor with Ki of <0.01 nM. B-cell lymphoma/leukemia 2 (Bcl-2) is an anti-apoptotic protein that controls cell survival by binding the BH3 domains of pro-death BAD and BAK proteins and preventing permeabilization of the mitochondrial outer membrane. This protein is tightly regulated for the homeostasis between cell growth and cell death.A Bcl-2-selective inhibitor with Ki of <0.01 nM